Daniel Wai

2.8k total citations
42 papers, 1.7k citations indexed

About

Daniel Wai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel Wai has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Pulmonary and Respiratory Medicine and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel Wai's work include Sarcoma Diagnosis and Treatment (19 papers), Lymphoma Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (4 papers). Daniel Wai is often cited by papers focused on Sarcoma Diagnosis and Treatment (19 papers), Lymphoma Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (4 papers). Daniel Wai collaborates with scholars based in United States, Germany and Japan. Daniel Wai's co-authors include Christopher Poremba, Karl‐Ludwig Schaefer, Barbara Dockhorn‐Dworniczak, Werner Boecker, Raihanatou Diallo, Toshifumi Ozaki, Yvonne Braun, F. van Valen, Poul H. Sorensen and Timothy J. Triche and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.

In The Last Decade

Daniel Wai

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Wai United States 22 945 616 514 362 252 42 1.7k
Igor Matushansky United States 21 1.1k 1.2× 576 0.9× 593 1.2× 313 0.9× 125 0.5× 48 1.8k
Yutaka Kawakami Japan 22 777 0.8× 409 0.7× 915 1.8× 305 0.8× 319 1.3× 37 2.4k
Irina A. Lubensky United States 26 1.1k 1.1× 815 1.3× 635 1.2× 652 1.8× 156 0.6× 41 2.2k
Maria Giulia Cangi Italy 21 914 1.0× 479 0.8× 878 1.7× 356 1.0× 419 1.7× 55 2.2k
Nadège Presneau United Kingdom 22 903 1.0× 1.4k 2.3× 332 0.6× 713 2.0× 211 0.8× 33 2.7k
Pierre Rudolph Germany 25 621 0.7× 323 0.5× 607 1.2× 335 0.9× 139 0.6× 41 1.5k
Kanako C. Hatanaka Japan 24 564 0.6× 409 0.7× 613 1.2× 400 1.1× 191 0.8× 143 2.0k
Jin Sung Jang United States 24 1.0k 1.1× 324 0.5× 516 1.0× 420 1.2× 96 0.4× 49 1.7k
Fumie Hosoda Japan 32 2.0k 2.1× 696 1.1× 1.1k 2.2× 746 2.1× 383 1.5× 53 3.6k
P Cairns United States 17 1.7k 1.8× 629 1.0× 599 1.2× 536 1.5× 437 1.7× 18 2.5k

Countries citing papers authored by Daniel Wai

Since Specialization
Citations

This map shows the geographic impact of Daniel Wai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wai more than expected).

Fields of papers citing papers by Daniel Wai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wai. The network helps show where Daniel Wai may publish in the future.

Co-authorship network of co-authors of Daniel Wai

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Wai. A scholar is included among the top collaborators of Daniel Wai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Wai. Daniel Wai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wai, Daniel, David W. Lee, Vijay Gokhale, et al.. (2019). In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells. BMC Cancer. 19(1). 1251–1251. 22 indexed citations
2.
Azorsa, David O., David W. Lee, Daniel Wai, et al.. (2018). Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis. Pediatric Blood & Cancer. 65(9). e27237–e27237. 13 indexed citations
3.
Farrar, Jason E., Rhonda E. Ries, Daniel Wai, et al.. (2016). Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse. Cancer Research. 76(8). 2197–2205. 104 indexed citations
4.
Christensen, Laura, et al.. (2013). FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma. PLoS ONE. 8(1). e54556–e54556. 35 indexed citations
5.
Kaddis, John S., Daniel Wai, Jessica Bowers, et al.. (2011). Influence of RNA Labeling on Expression Profiling of MicroRNAs. Journal of Molecular Diagnostics. 14(1). 12–21. 1 indexed citations
6.
Potratz, Jenny, Darren N. Saunders, Daniel Wai, et al.. (2010). Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas. Cancer Research. 70(21). 8770–8781. 55 indexed citations
7.
Hu, Kaiji, Cathy Lee, Dexin Qiu, et al.. (2009). Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas. Molecular Cancer Therapeutics. 8(11). 3024–3035. 48 indexed citations
8.
Davicioni, Elai, Daniel Wai, & Michael J. Anderson. (2008). Diagnostic and Prognostic Sarcoma Signatures. Molecular Diagnosis & Therapy. 12(6). 359–374. 16 indexed citations
9.
Schaefer, Karl‐Ludwig, Martin Eisenacher, Yvonne Braun, et al.. (2008). Microarray analysis of Ewing’s sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. European Journal of Cancer. 44(5). 699–709. 77 indexed citations
10.
Schaefer, Karl‐Ludwig, Yvonne Braun, Raihanatou Diallo, et al.. (2006). Constitutive Activation of Neuregulin/ERBB3 Signaling Pathway in Clear Cell Sarcoma of Soft Tissue. Neoplasia. 8(7). 613–622. 21 indexed citations
11.
Schaefer, Karl‐Ludwig, Daniel Wai, Yvonne Braun, et al.. (2004). Expression Profiling of t(12;22) Positive Clear Cell Sarcoma of Soft Tissue Cell Lines Reveals Characteristic Up-Regulation of Potential New Marker Genes Including ERBB3 . Cancer Research. 64(10). 3395–3405. 56 indexed citations
12.
Ozaki, Toshifumi, Karl‐Ludwig Schaefer, Daniel Wai, et al.. (2002). Population-based genetic alterations in Ewing’s tumors from Japanese and European Caucasian patients. Annals of Oncology. 13(10). 1656–1664. 24 indexed citations
13.
Böcker, W., Roland Moll, Christopher Poremba, et al.. (2002). Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept. Laboratory Investigation. 82(6). 737–745. 223 indexed citations
14.
Schaefer, Karl‐Ludwig, Daniel Wai, Christopher Poremba, et al.. (2002). Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray‐based sequencing technology. Medical and Pediatric Oncology. 38(4). 247–253. 8 indexed citations
15.
Schuck, Andreas, Christopher Poremba, Claudia Lanvers, et al.. (2002). Radiation-Induced Changes of Telomerase Activity in a Human Ewing Xenograft Tumor. Strahlentherapie und Onkologie. 178(12). 701–708. 15 indexed citations
16.
Ozaki, Toshifumi, Karl‐Ludwig Schaefer, Daniel Wai, et al.. (2002). Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas. International Journal of Cancer. 102(4). 355–365. 74 indexed citations
17.
Poremba, Christopher, Bernhard Heine, Raihanatou Diallo, et al.. (2002). Telomerase as a prognostic marker in breast cancer: high‐throughput tissue microarray analysis of hTERT and hTR. The Journal of Pathology. 198(2). 181–189. 106 indexed citations
18.
Wai, Daniel, Christopher Poremba, Eberhard Korsching, et al.. (2002). Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 440(5). 476–484. 21 indexed citations
19.
Scheel, Christina, Karl‐Ludwig Schaefer, Anna Jauch, et al.. (2001). Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene. 20(29). 3835–3844. 139 indexed citations
20.
Ozaki, Toshifumi, Michael Paulussen, Christopher Poremba, et al.. (2001). Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors. Genes Chromosomes and Cancer. 32(2). 164–171. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026